BNP Paribas Arbitrage SA Boosts Stock Position in National Health Investors Inc (NYSE:NHI)

BNP Paribas Arbitrage SA grew its holdings in National Health Investors Inc (NYSE:NHI) by 282.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 36,604 shares of the real estate investment trust’s stock after buying an additional 27,022 shares during the quarter. BNP Paribas Arbitrage SA owned 0.08% of National Health Investors worth $1,813,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of the company. Sei Investments Co. increased its position in shares of National Health Investors by 1.7% in the fourth quarter. Sei Investments Co. now owns 7,720 shares of the real estate investment trust’s stock valued at $629,000 after buying an additional 129 shares in the last quarter. Oppenheimer Asset Management Inc. increased its position in shares of National Health Investors by 26.8% in the first quarter. Oppenheimer Asset Management Inc. now owns 990 shares of the real estate investment trust’s stock valued at $49,000 after buying an additional 209 shares in the last quarter. Van ECK Associates Corp increased its position in shares of National Health Investors by 108.4% in the first quarter. Van ECK Associates Corp now owns 521 shares of the real estate investment trust’s stock valued at $26,000 after buying an additional 271 shares in the last quarter. Alliancebernstein L.P. increased its position in shares of National Health Investors by 0.4% in the fourth quarter. Alliancebernstein L.P. now owns 73,418 shares of the real estate investment trust’s stock valued at $5,982,000 after buying an additional 285 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. increased its position in shares of National Health Investors by 3.5% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 8,532 shares of the real estate investment trust’s stock valued at $695,000 after buying an additional 286 shares in the last quarter. Institutional investors and hedge funds own 68.95% of the company’s stock.

In other National Health Investors news, Director Robert T. Webb purchased 2,151 shares of the firm’s stock in a transaction dated Monday, March 16th. The shares were acquired at an average price of $46.28 per share, with a total value of $99,548.28. Following the purchase, the director now directly owns 63,339 shares in the company, valued at approximately $2,931,328.92. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director W Andrew Adams purchased 27,000 shares of the firm’s stock in a transaction dated Monday, March 23rd. The stock was acquired at an average cost of $36.16 per share, for a total transaction of $976,320.00. Following the purchase, the director now owns 759,784 shares in the company, valued at $27,473,789.44. The disclosure for this purchase can be found here. Insiders have acquired 29,576 shares of company stock worth $1,096,421 in the last three months. 5.74% of the stock is currently owned by corporate insiders.

NHI has been the subject of several research reports. JMP Securities initiated coverage on National Health Investors in a research report on Monday. They set a “market perform” rating for the company. KeyCorp dropped their price target on National Health Investors from $43.00 to $40.00 and set an “underweight” rating for the company in a research report on Thursday, May 14th. Mizuho cut National Health Investors from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $60.00 to $55.00 in a research report on Friday, May 22nd. SunTrust Banks dropped their price target on National Health Investors from $77.00 to $61.00 and set a “hold” rating for the company in a research report on Thursday, April 23rd. Finally, ValuEngine cut National Health Investors from a “hold” rating to a “sell” rating in a research report on Thursday, April 2nd. Three research analysts have rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the stock. National Health Investors currently has an average rating of “Hold” and an average target price of $67.57.

NYSE NHI opened at $57.08 on Friday. The stock’s fifty day moving average is $54.37 and its two-hundred day moving average is $69.28. The firm has a market capitalization of $2.81 billion, a P/E ratio of 11.32 and a beta of 0.84. The company has a debt-to-equity ratio of 1.03, a quick ratio of 12.05 and a current ratio of 12.05. National Health Investors Inc has a fifty-two week low of $31.37 and a fifty-two week high of $91.12.

National Health Investors (NYSE:NHI) last released its quarterly earnings data on Monday, May 11th. The real estate investment trust reported $1.37 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.40 by ($0.03). The company had revenue of $83.08 million for the quarter, compared to analyst estimates of $80.77 million. National Health Investors had a return on equity of 12.62% and a net margin of 57.16%. The business’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period last year, the firm posted $1.31 EPS. As a group, sell-side analysts forecast that National Health Investors Inc will post 5.61 EPS for the current year.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Featured Article: Trading Ex-Dividend Strategy

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.